Implementation of Genetic Algorithms and Momentum Backpropagation in Classification of Subtype Cells Acute Myeloid Leukimia

Abstract

 Acute Myeloid Leukimia (AML) is a type of cancer which attacks white blood cells from myeloid. AML subtypes M1, M2, and M3 are affected by the same type of cells called myeloblasts, so it needs more detailed analysis to classify.Momentum Backpropagation  is used to classified. In its application, optimal selection of architecture, learning rate, and momentum is still done by random trial. This is one of the disadvantage of Momentum Backpropagation. This study uses a genetic algorithm (GA) as an optimization method to get the best architecture, learning rate, and momentum of artificial neural network. Genetic algorithms are one of the optimization techniques that emulate the process of biological evolution.

The dataset used in this study is numerical feature data resulting from the segmentation of white blood cell images taken from previous studies which has been done by Nurcahya Pradana Taufik Prakisya. Based on these data, an evaluation of the Momentum Backpropagation process was conducted the selection parameter in a random trial with the genetic algorithm. Furthermore, the comparison of accuracy values was carried out as an alternative to the ANN learning method that was able to provide more accurate values with the data used in this study.

The results showed that training and testing with genetic algorithm optimization of ANN parameters resulted in an average memorization accuracy of 83.38% and validation accuracy of 94.3%. Whereas in other ways, training and testing with momentum backpropagation random trial resulted in an average memorization accuracy of 76.09% and validation accuracy of 88.22%.